Showing results (121-130 of 151) with videos related to
Sort By:
Pageof 16
Journal of Translational Medicine|January 4, 2024
Virus-like particle-mediated delivery of structure-selected neoantigens demonstrates immunogenicity and antitumoral activity in miceAna Barajas, Pep Amengual-Rigo, Anna Pons-Grífols, et al.NPJ Vaccines|April 6, 2023
An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responsesFerran Tarrés-Freixas, Carmen Aguilar-Gurrieri, María Luisa Rodríguez de la Concepción, et al.Med (New York, N.Y.)|February 8, 2021
Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodesEdwards Pradenas, Benjamin Trinité, Víctor Urrea, et al.Viruses|July 2, 2021
Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated IndividualsBenjamin Trinité, Edwards Pradenas, Silvia Marfil, et al.NPJ Vaccines|February 27, 2024
Immunisation efficacy of a stabilised SARS-CoV-2 spike glycoprotein in two geriatric animal modelsCarla Usai, Erola Ainsua-Enrich, Victor Urrea Gales, et al.The Journal of Experimental Medicine|September 14, 2016
The soluble pattern recognition receptor PTX3 links humoral innate and adaptive immune responses by helping marginal zone B cellsAlejo Chorny, Sandra Casas-Recasens, Jordi Sintes, et al.Mucosal Immunology|September 2, 2018
Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infectionYolanda Guillén, Marc Noguera-Julian, Javier Rivera, et al.Ebiomedicine|April 13, 2023
Macrophage CD5L is a target for cancer immunotherapyLidia Sanchez-Moral, Tony Paul, Clara Martori, et al.Scientific Reports|January 29, 2021
SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severityBenjamin Trinité, Ferran Tarrés-Freixas, Jordi Rodon, et al.JAMA Oncology|April 10, 2020
Assessment of the Feasibility and Safety of Durvalumab for Treatment of Solid Tumors in Patients With HIV-1 Infection: The Phase 2 DURVAST StudyMaria Gonzalez-Cao, Teresa Morán, Judith Dalmau, et al.Pageof 16